| Primary |
| Urinary Tract Infection |
24.1% |
| Prophylaxis |
18.5% |
| Cellulitis |
14.8% |
| Furuncle |
5.6% |
| Abscess |
3.7% |
| Ear Infection |
3.7% |
| Sinusitis |
3.7% |
| Staphylococcal Infection |
3.7% |
| Acne |
1.9% |
| Asthma |
1.9% |
| Atrial Fibrillation |
1.9% |
| Bacterial Infection |
1.9% |
| Blastomycosis |
1.9% |
| Bronchitis |
1.9% |
| Diabetic Foot Infection |
1.9% |
| Epididymitis |
1.9% |
| Hypersensitivity |
1.9% |
| Hypertension |
1.9% |
| Infection |
1.9% |
| Musculoskeletal Stiffness |
1.9% |
|
| Rash |
15.5% |
| Stevens-johnson Syndrome |
13.8% |
| Urticaria |
10.3% |
| Drug Hypersensitivity |
8.6% |
| Vomiting |
8.6% |
| Hypersensitivity |
5.2% |
| Pruritus |
5.2% |
| Pyrexia |
5.2% |
| Renal Failure Acute |
5.2% |
| Angioedema |
3.4% |
| Swelling |
3.4% |
| Ageusia |
1.7% |
| Dermatitis |
1.7% |
| Diabetes Mellitus Inadequate Control |
1.7% |
| Drug Dispensing Error |
1.7% |
| Dyspepsia |
1.7% |
| Feeling Abnormal |
1.7% |
| Headache |
1.7% |
| Hepatic Enzyme Abnormal |
1.7% |
| Loss Of Proprioception |
1.7% |
|
| Secondary |
| Urinary Tract Infection |
13.3% |
| Product Used For Unknown Indication |
12.0% |
| Sinus Disorder |
8.0% |
| Viral Infection |
8.0% |
| Atrial Fibrillation |
6.7% |
| Hypertension |
6.7% |
| Benign Prostatic Hyperplasia |
5.3% |
| Blood Cholesterol Increased |
4.0% |
| Cellulitis |
4.0% |
| Drug Use For Unknown Indication |
4.0% |
| Nasal Congestion |
4.0% |
| Bronchitis |
2.7% |
| Cystitis |
2.7% |
| Glioblastoma |
2.7% |
| Hypersensitivity |
2.7% |
| Infection |
2.7% |
| Psoriasis |
2.7% |
| Smoking Cessation Therapy |
2.7% |
| Subcutaneous Abscess |
2.7% |
| Wound Infection |
2.7% |
|
| Paraesthesia |
11.5% |
| Pseudomonas Infection |
7.7% |
| Renal Failure Acute |
7.7% |
| Swelling |
7.7% |
| Wound Infection |
7.7% |
| Adverse Drug Reaction |
3.8% |
| Coagulopathy |
3.8% |
| Convulsion |
3.8% |
| Decreased Appetite |
3.8% |
| Drug Hypersensitivity |
3.8% |
| Drug Interaction |
3.8% |
| Fall |
3.8% |
| Hypersensitivity |
3.8% |
| Impaired Driving Ability |
3.8% |
| International Normalised Ratio Increased |
3.8% |
| Jaundice |
3.8% |
| Lethargy |
3.8% |
| Lymphadenopathy |
3.8% |
| Mental Status Changes |
3.8% |
| Muscle Atrophy |
3.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
30.8% |
| Drug Use For Unknown Indication |
16.6% |
| Hiv Infection |
12.6% |
| Pain |
4.3% |
| Prophylaxis Against Transplant Rejection |
4.1% |
| Multiple Myeloma |
3.9% |
| Prophylaxis |
3.1% |
| Chronic Lymphocytic Leukaemia |
2.9% |
| Acne |
2.7% |
| Breast Cancer Metastatic |
2.3% |
| Hypertension |
2.0% |
| Nausea |
2.0% |
| Depression |
2.0% |
| Anxiety |
1.9% |
| Urinary Tract Infection |
1.9% |
| Contraception |
1.8% |
| Hiv Test |
1.4% |
| Vitamin Supplementation |
1.3% |
| Infection Prophylaxis |
1.2% |
| Uveitis |
1.2% |
|
| Vomiting |
11.0% |
| Weight Decreased |
10.4% |
| Thrombocytopenia |
8.2% |
| Pyrexia |
6.6% |
| Leukopenia |
6.0% |
| Tooth Extraction |
4.9% |
| Hypotension |
4.4% |
| Renal Failure Acute |
4.4% |
| Urinary Tract Infection |
4.4% |
| Death |
3.8% |
| Deep Vein Thrombosis |
3.8% |
| Fallot's Tetralogy |
3.8% |
| Neutropenia |
3.8% |
| Pulmonary Embolism |
3.8% |
| Urinary Incontinence |
3.8% |
| Pancytopenia |
3.3% |
| Renal Failure |
3.3% |
| Spine Malformation |
3.3% |
| Transplant Rejection |
3.3% |
| Vena Cava Thrombosis |
3.3% |
|
| Interacting |
| Convulsion Prophylaxis |
40.0% |
| Urinary Tract Infection |
40.0% |
| Lung Neoplasm |
20.0% |
|
| Apraxia |
50.0% |
| Toxicity To Various Agents |
50.0% |
|
